Three or more cups of coffee daily halves mortality risk in patients with both HIV and HCV

September 25, 2017, Elsevier
Drinking three or more cups of coffee a day halves mortality risk from all causes in HIV-HCV co-infected patients. Credit: Journal of Hepatology

Patients infected by both human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are at specific risk of end-stage liver disease and greater risk of cardiovascular diseases and cancer. In addition, HIV infection accelerates the progression of chronic hepatitis C to fibrosis and development of cirrhosis and end-stage liver disease. In these HIV-HCV co-infected patients, drinking at least three cups of coffee each day halved the risk of all-cause mortality according to a new study published in the Journal of Hepatology.

This study is the first to investigate the relationship between coffee consumption and the of all-cause mortality in HIV-HCV co-infected patients. "This is a very exciting time for HCV research as a cure that can eradicate the virus is now available for all patients," explained lead investigator Dominique Salmon-Céron, MD, PhD, of the Service des Maladies Infectieuses et Tropicales, Hôpital Cochin, and Université Paris Descartes, Paris, France. "However, even when cured of HCV, patients co-infected with HIV have a higher risk of death with respect to the , due to an accelerated aging process that may result from cancer, complications related to diabetes and to liver disease, and from cardiovascular events."

Coffee is known to have anti-inflammatory and liver-protective properties. In the general population, drinking three or more cups of coffee a day has been found to be associated with a 14% reduction in the risk of all-cause mortality. This is probably due to the properties of polyphenols contained in coffee that can protect the liver and also reduce inflammation.

Investigators used data from a five-year follow-up of 1,028 HIV-HCV co-infected patients enrolled in the French national ANRS CO13-HEPAVIH cohort. ANRS CO13-HEPAVIH is an ongoing French nationwide prospective cohort of HIV-HCV co-infected patients that collects both medical and psychosocial/behavioral data over time via annual self-administered questionnaires.

At enrolment, one in four patients reported drinking at least three cups of coffee daily. Over the five years, 77 deaths occurred, almost half attributable to hepatitis C. However, the mortality risk was 80% lower in those who were cured of (i.e. who "cleared") hepatitis C thanks to treatment.

Further analysis showed that drinking at least three cups of coffee daily was associated with a 50% reduction in mortality risk even after taking into account HCV clearance, HIV- and HCV-related factors, and other sociobehavioral factors, such as having a steady partner and not smoking. Healthy behavior change should be promoted by physicians following HCV clearance.

This research highlights the importance of behaviors - coffee consumption and not smoking in particular - on reduced . These results can help promote behavioral changes in HIV-HCV patients, which in turn can result in improved survival. With respect to coffee consumption, individuals who do not drink coffee because of caffeine can still benefit from the comparable anti-inflammatory effects of decaffeinated coffee.

First author Maria Patrizia Carrieri, PhD, of the HEPAVIH Study Group, Faculté de Médecine, Aix Marseille University, INSERM, IRD, SESSTIM, Marseilles, France, observed that coffee consumption provides more protective effects on mortality in the HIV-HCV population than in the general population.

"The results of our study show that while curing HCV is fundamental, it must be complemented by behavioral changes if we are to improve health and survival in HIV-infected patients whether or not they cleared HCV. "I think we need to better monitor , together with other behaviors, such as alcohol use, smoking, physical activity, and to propose interventions to our patients which facilitate healthy behaviors even after HCV clearance. We also suggest that those patients who cannot tolerate a high intake of caffeine should consider drinking a few cups of decaffeinated coffee a day," commented Dr. Salmon-Céron. "Accordingly, I believe that the benefits of extracts and supplementing dietary intake with other anti-inflammatory compounds need to be evaluated in HIV-HCV ."

Explore further: Higher coffee consumption associated with lower risk of death

More information: Maria Patrizia Carrieri et al, Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients, Journal of Hepatology (2017). DOI: 10.1016/j.jhep.2017.08.005

Related Stories

Higher coffee consumption associated with lower risk of death

August 28, 2017
Higher coffee consumption is associated with a lower risk of death, according to research presented today at ESC Congress. The observational study in nearly 20 000 participants suggests that coffee can be part of a healthy ...

Caffeine linked to lower risk of death in women with diabetes

September 13, 2017
Women with diabetes who regularly drink caffeinated coffee or tea may live longer than those who don't consume caffeine at all, according to new research being presented at this year's European Association for the Study of ...

Drinking more coffee could reduce liver cancer risk, suggests study

May 29, 2017
Drinking more coffee could reduce the risk of developing the most common form of primary liver cancer, according to a study led by the University of Southampton.

Does coffee help you live longer?

August 2, 2017
Can drinking coffee help you live longer? Two studies report that it may be true.

Drinking coffee may reduce the risk of liver cirrhosis

February 1, 2016
Regular consumption of coffee was linked with a reduced risk of liver cirrhosis in a review of relevant studies published before July 2015.

Drinking coffee may slow progression of liver disease

February 26, 2016
(HealthDay)—Regular coffee consumption seems to delay disease progression in alcoholic liver disease (ALD) and primary sclerosing cholangitis (PSC) patients with end-stage liver disease (ESLD) and increase long-term survival ...

Recommended for you

Hot cars can hit deadly temperatures in as little as one hour

May 24, 2018
A lot can happen at 160 degrees Fahrenheit: Eggs fry, salmonella bacteria dies, and human skin will suffer third-degree burns. If a car is parked in the sun on a hot summer day, its dashboard can hit 160 degrees in about ...

Research finds a little exercise does a lot of good for ageing muscles

May 24, 2018
Getting old doesn't necessarily mean getting weak and frail – just a little bit of exercise can help maintain muscle mass and strength, Otago research has revealed.

In helping smokers quit, cash is king, e-cigarettes strike out

May 23, 2018
Free smoking cessation aids, such as nicotine patches and chewing gum, are a staple of many corporate wellness programs aimed at encouraging employees to kick the habit. But, new research shows that merely offering such aids ...

What makes us well? Diversity, health care, and public transit matter

May 23, 2018
Diverse neighbors. Health centers. Commuter trains. These community attributes, and other key factors, are linked to well-being and quality of life, according to Yale researchers.

Time spent sitting at a screen matters less if you are fit and strong

May 23, 2018
The impact of screen time on cardiovascular disease, cancer incidence and mortality may be greatest in people who have lower levels of grip-strength, fitness and physical activity, according to a study published in the open ...

Widely used e-cigarette flavoring impairs lung function

May 23, 2018
A new study has found that a common e-cigarette flavoring that has chemical characteristics similar to toxic chemicals found in cigarette smoke disrupts an important mechanism of the lungs' antibacterial defense system. The ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.